Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Costanza Rovida

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
ALTEX|June 1, 2011
Local lymph node assay: how testing laboratories apply OECD TG 429 for REACH purposesCostanza Rovida
ALTEX|November 30, 2010
Food for thought ... why no new in vitro tests will be done for REACH by registrantsCostanza Rovida
ALTEX|October 21, 2010
That which must not, can not be... A reply to the EChA and EDF responses to the REACH analysis of animal use and costsThomas Hartung, Costanza Rovida
Frontiers in Toxicology|January 2, 2026
Mechanistic read-across comes of age: a comparative appraisal of EFSA 2025 guidance, ECHA's RAAF, and good read-across practiceThomas Hartung, Costanza Rovida
ALTEX|November 13, 2009
Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4))Costanza Rovida, Thomas Hartung
Nature|August 29, 2009
Chemical regulators have overreachedThomas Hartung, Costanza Rovida
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2024
Integration of QSAR and NAM in the Read-Across Process for an Effective and Relevant Toxicological AssessmentCostanza Rovida, Marina Muscarella, Monica Locatelli
ALTEX|July 14, 2016
Two Good Read-across Practice workshops. Making it work for you!Alexandra Maertens, Bruno Hubesch, Costanza Rovida
ALTEX|April 12, 2022
On the usefulness of animals as a model system (part I): Overview of criteria and focus on robustnessGiorgia Pallocca, Costanza Rovida, Marcel Leist
ALTEX|July 20, 2023
4.2 million and counting… The animal toll for REACH systemic toxicity studiesJean Knight, Thomas Hartung, Costanza Rovida
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
ALTEX|June 1, 2011
Local lymph node assay: how testing laboratories apply OECD TG 429 for REACH purposesCostanza Rovida
ALTEX|November 30, 2010
Food for thought ... why no new in vitro tests will be done for REACH by registrantsCostanza Rovida
ALTEX|October 21, 2010
That which must not, can not be... A reply to the EChA and EDF responses to the REACH analysis of animal use and costsThomas Hartung, Costanza Rovida
Frontiers in Toxicology|January 2, 2026
Mechanistic read-across comes of age: a comparative appraisal of EFSA 2025 guidance, ECHA's RAAF, and good read-across practiceThomas Hartung, Costanza Rovida
ALTEX|November 13, 2009
Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4))Costanza Rovida, Thomas Hartung
Nature|August 29, 2009
Chemical regulators have overreachedThomas Hartung, Costanza Rovida
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2024
Integration of QSAR and NAM in the Read-Across Process for an Effective and Relevant Toxicological AssessmentCostanza Rovida, Marina Muscarella, Monica Locatelli
ALTEX|July 14, 2016
Two Good Read-across Practice workshops. Making it work for you!Alexandra Maertens, Bruno Hubesch, Costanza Rovida
ALTEX|April 12, 2022
On the usefulness of animals as a model system (part I): Overview of criteria and focus on robustnessGiorgia Pallocca, Costanza Rovida, Marcel Leist
ALTEX|July 20, 2023
4.2 million and counting… The animal toll for REACH systemic toxicity studiesJean Knight, Thomas Hartung, Costanza Rovida
Pageof 6